Found: 120
Select item for more details and to access through your institution.
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 477, doi. 10.1007/s10637-020-01010-4
- By:
- Publication type:
- Article
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 3, p. 635, doi. 10.1007/s00520-014-2405-y
- By:
- Publication type:
- Article
A novel image deep learning–based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.
- Published in:
- European Radiology, 2024, v. 34, n. 3, p. 2048, doi. 10.1007/s00330-023-10026-2
- By:
- Publication type:
- Article
Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives.
- Published in:
- Cancer Communications, 2021, v. 41, n. 12, p. 1252, doi. 10.1002/cac2.12237
- By:
- Publication type:
- Article
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors.
- Published in:
- Cancer Communications, 2021, v. 41, n. 11, p. 1243, doi. 10.1002/cac2.12202
- By:
- Publication type:
- Article
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Percutaneous superfine-needle aspiration biopsy of intrathoracic lesions guided by simulator.
- Published in:
- Journal of Surgical Oncology, 1989, v. 40, n. 2, p. 135, doi. 10.1002/jso.2930400215
- By:
- Publication type:
- Article
Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular Docking.
- Published in:
- Molecules, 2021, v. 26, n. 14, p. 4361, doi. 10.3390/molecules26144361
- By:
- Publication type:
- Article
Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1515
- By:
- Publication type:
- Article
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00245-y
- By:
- Publication type:
- Article
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
- By:
- Publication type:
- Article
Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.596937
- By:
- Publication type:
- Article
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6
- By:
- Publication type:
- Article
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
- Published in:
- Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z
- By:
- Publication type:
- Article
Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 1, p. 109, doi. 10.1007/s10585-020-10062-y
- By:
- Publication type:
- Article
Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231193726
- By:
- Publication type:
- Article
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818
- By:
- Publication type:
- Article
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138380
- By:
- Publication type:
- Article
ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules—A Large Study of 2022 Cases in China.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7400, doi. 10.1245/s10434-023-14009-x
- By:
- Publication type:
- Article
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 10, p. 3808, doi. 10.1245/s10434-020-08400-1
- By:
- Publication type:
- Article
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A three-dimensional printing navigational template combined with mixed reality technique for localizing pulmonary nodules.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2021, v. 32, n. 4, p. 552, doi. 10.1093/icvts/ivaa300
- By:
- Publication type:
- Article
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00301-8
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01403-w
- By:
- Publication type:
- Article
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00470-z
- By:
- Publication type:
- Article
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00465-w
- By:
- Publication type:
- Article
Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1683
- By:
- Publication type:
- Article
Poor prognosis of intra‐tumoural TRBV6‐6 variants in EGFR‐mutant NSCLC: Results from the ADJUVANT‐CTONG1104 trial.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.775
- By:
- Publication type:
- Article
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 1, p. 337, doi. 10.1002/ctm2.12
- By:
- Publication type:
- Article
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09762-1
- By:
- Publication type:
- Article
Familial association of lung cancer with liver cancer in first-degree relatives.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5813, doi. 10.2147/CMAR.S199462
- By:
- Publication type:
- Article
Emerging evidence and treatment paradigm of non-small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01436-2
- By:
- Publication type:
- Article
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2023, v. 64, n. 6, p. 1, doi. 10.1093/ejcts/ezad373
- By:
- Publication type:
- Article
Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Heterogeneity in the immune microenvironment of bone metastasis in driver‐positive non‐small cell lung cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 7, p. 1001, doi. 10.1002/mc.23541
- By:
- Publication type:
- Article
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 267, doi. 10.1007/s10147-019-01552-5
- By:
- Publication type:
- Article
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 61, doi. 10.1634/theoncologist.2016-0150
- By:
- Publication type:
- Article
Lung Cancer Treatment Disparities in China: A Question in Need of an Answer.
- Published in:
- Oncologist, 2014, v. 19, n. 10, p. 1084, doi. 10.1634/theoncologist.2014-0007
- By:
- Publication type:
- Article
Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules.
- Published in:
- Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1663666
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 22, p. 3174, doi. 10.1111/1759-7714.14672
- By:
- Publication type:
- Article
Dynamic <sup>18</sup>F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 17, p. 2524, doi. 10.1111/1759-7714.14562
- By:
- Publication type:
- Article